For fiscal 2026 (ended Jun 30, 2026), Amesite Inc. reported $364.8K of revenue and -$3.10M of net income.
AMST revenue was $79.1K in fiscal Q4 2026 (ended Jun 30, 2026), up 41.9% from a year earlier and down 5.1% from the prior quarter. For the full fiscal 2026 it was $364.8K, up 230.2% from fiscal 2025. Compound annual growth was -11.6% over 5 years. It rose in 4 of the last 6 fiscal years.
AMST net income was -$1.04M in fiscal Q4 2026 (ended Jun 30, 2026), compared with -$924.0K a year earlier. For the full fiscal 2026 it was -$3.10M, compared with -$3.62M in fiscal 2025.
AMST diluted EPS was -$0.63 for fiscal 2026 (ended Jun 30, 2026), compared with -$1.03 in fiscal 2025.
AMST free cash flow was -$2.15M for fiscal 2026 (ended Jun 30, 2026).
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $364.8K | $110.5K | $166.9K | $845.0K | $697.0K | $674.6K | $59.7K |
| Research and development | $613.6K | $691.2K | $1.07M | $1.52M | $3.06M | - | - |
| Selling, general and admin | $2.51M | $2.48M | $2.91M | $2.49M | $5.18M | $4.62M | $2.05M |
| Operating income | -$3.14M | -$3.60M | -$4.58M | -$4.22M | -$9.06M | - | - |
| Net income | -$3.10M | -$3.62M | -$4.40M | -$4.15M | -$9.06M | -$11.59M | -$4.17M |
| EPS, basic | -$0.63 | -$1.03 | -$1.73 | -$1.68 | -$4.67 | -$0.59 | -$0.27 |
| EPS, diluted | -$0.63 | -$1.03 | -$1.73 | -$1.68 | -$4.67 | -$0.59 | - |
| Diluted shares | - | - | - | - | 23.3M | 19.5M | 15.4M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.30M | $2.33M | $2.17M | $5.36M | $7.06M | $10.71M | $4.09M |
| Receivables | $14.7K | $6.3K | $30.1K | $15.0K | $14.5K | $51.1K | $61.1K |
| Current assets | $2.41M | $2.43M | $2.50M | $5.48M | $7.73M | $11.06M | - |
| Total assets | $3.03M | $3.10M | $3.31M | $6.35M | $8.88M | $12.48M | $5.70M |
| Current liabilities | $375.9K | $358.6K | $798.5K | $265.3K | $748.1K | $741.7K | $2.70M |
| Total debt | - | - | - | - | - | - | $2.03M |
| Total liabilities | - | - | - | - | - | - | $2.70M |
| Shareholders' equity | $2.65M | $2.74M | $2.52M | $6.08M | $8.14M | $11.74M | $3.00M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.15M | -$2.46M | -$2.81M | -$3.25M | -$6.72M | -$5.33M | -$2.81M |
| Capital expenditures | $5.7K | - | $1.2K | $27.1K | $16.6K | $73.4K | $10.8K |
| Free cash flow | -$2.15M | - | -$2.81M | -$3.28M | -$6.73M | -$5.41M | -$2.82M |
| Investing cash flow | -$230.8K | -$378.3K | -$375.9K | -$396.0K | -$711.6K | -$842.3K | -$795.7K |
| Financing cash flow | $2.34M | $3.10M | - | $1.85M | $3.87M | $12.80M | $6.69M |
| Stock-based compensation | $268.1K | $322.0K | $834.5K | $179.5K | $1.44M | $876.3K | $555.0K |
| Depreciation and amortization | $277.4K | $433.8K | $533.7K | $682.5K | $875.6K | $751.5K | $522.3K |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 230.2% | -33.8% | -80.3% | 21.2% | 3.3% | 1029.0% | - |
| Operating margin | -861.7% | -3262.4% | -2744.3% | -499.9% | -1299.4% | - | - |
| Net margin | -848.7% | -3274.6% | -2638.5% | -491.5% | -1299.8% | -1717.6% | -6979.7% |
| Free cash flow margin | -590.1% | - | -1686.8% | -387.7% | -965.9% | -801.7% | -4721.2% |
| Return on equity | -116.7% | -132.1% | -175.0% | -68.3% | -111.4% | -98.7% | -139.0% |
| Return on assets | -102.2% | -116.8% | -132.9% | -65.4% | -102.0% | -92.9% | -73.1% |
| Current ratio | 6.42 | 6.79 | 3.14 | 20.66 | 10.33 | 14.92 | - |
| Debt to equity | - | - | - | - | - | - | 0.68 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79.1K | $83.3K | $108.0K | $94.3K | $55.8K | $30.7K | $12.8K | $11.3K | $27.8K | $34.3K | $41.4K | $63.3K |
| Research and development | $211.6K | $134.2K | $164.9K | $102.9K | $167.5K | $172.1K | $211.9K | $139.7K | $185.8K | $223.8K | $331.2K | $333.4K |
| Selling, general and admin | $834.5K | $549.8K | $578.9K | $547.1K | $611.6K | $428.5K | $804.7K | $633.1K | $891.4K | $1.13M | $443.8K | $438.3K |
| Operating income | -$1.05M | -$684.1K | -$745.3K | -$662.1K | -$857.7K | -$687.7K | -$1.13M | -$927.3K | -$1.21M | -$1.46M | -$956.1K | -$950.0K |
| Net income | -$1.04M | -$678.1K | -$732.5K | -$642.3K | -$924.0K | -$663.4K | -$1.12M | -$908.0K | -$1.18M | -$1.43M | -$905.6K | -$890.7K |
| EPS, basic | - | -$0.15 | -$0.16 | -$0.14 | - | -$0.16 | -$0.40 | -$0.34 | - | -$0.56 | -$0.36 | -$0.35 |
| EPS, diluted | - | -$0.15 | -$0.16 | -$0.14 | - | -$0.16 | -$0.40 | -$0.34 | - | -$0.56 | -$0.36 | -$0.35 |
| Diluted shares | - | - | - | - | - | 4.1M | - | - | - | 2.5M | - | - |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.30M | $640.7K | $1.17M | $1.83M | $2.33M | $2.96M | $619.7K | $1.43M | $2.17M | $2.97M | $3.66M | $4.64M |
| Receivables | $14.7K | $19.0K | $7.2K | $10.3K | $6.3K | $4.4K | - | - | $30.1K | - | - | $18.8K |
| Current assets | $2.41M | $822.0K | $1.33M | $1.91M | $2.43M | $3.14M | $1.45M | $2.43M | $2.50M | $3.15M | $3.86M | $4.73M |
| Total assets | $3.03M | $1.49M | $2.00M | $2.60M | $3.10M | $3.81M | $2.14M | $3.17M | $3.31M | $3.83M | $4.55M | $5.51M |
| Current liabilities | $375.9K | $190.0K | $489.8K | $427.6K | $358.6K | $211.0K | $888.7K | $843.0K | $798.5K | $211.7K | $176.0K | $263.3K |
| Shareholders' equity | $2.65M | $1.30M | $1.51M | $2.17M | $2.74M | $3.60M | $1.25M | $2.33M | $2.52M | $3.62M | $4.38M | $5.25M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$660.7K | -$449.2K | -$621.1K | -$415.8K | -$439.4K | -$677.1K | -$850.4K | -$488.3K | -$654.4K | -$581.5K | -$919.1K | -$658.8K |
| Capital expenditures | - | - | - | - | - | - | - | - | $0 | $0 | - | - |
| Free cash flow | - | - | - | - | - | - | - | - | -$654.4K | -$581.5K | - | - |
| Investing cash flow | -$24.1K | -$75.5K | -$43.6K | -$87.6K | -$86.1K | -$79.6K | -$64.6K | -$148.0K | -$147.1K | -$109.4K | -$54.2K | -$65.2K |
| Financing cash flow | - | - | - | - | $0 | - | - | - | - | - | - | $0 |
| Stock-based compensation | $51.4K | $72.3K | $72.3K | $72.3K | $360.2K | -$144.6K | $41.0K | $65.4K | $73.7K | $672.5K | $33.1K | $55.1K |
| Depreciation and amortization | $77.9K | $71.4K | $67.7K | $60.4K | $102.1K | $100.5K | $112.9K | $118.3K | $119.5K | $122.2K | $139.7K | $152.4K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 41.9% | 171.5% | 746.8% | 738.2% | 100.3% | -10.4% | -69.2% | -82.2% | -77.4% | -83.3% | -82.5% | -77.4% |
| Operating margin | -1329.5% | -820.9% | -689.7% | -702.2% | -1538.2% | -2240.9% | -8862.6% | -8243.1% | -4344.9% | -4272.4% | -2307.0% | -1500.0% |
| Net margin | -1318.6% | -813.7% | -678.0% | -681.1% | -1657.1% | -2161.7% | -8790.3% | -8071.5% | -4241.4% | -4161.9% | -2185.2% | -1406.4% |
| Free cash flow margin | - | - | - | - | - | - | - | - | -2350.3% | -1697.4% | - | - |
| Current ratio | 6.42 | 4.33 | 2.72 | 4.46 | 6.79 | 14.88 | 1.63 | 2.88 | 3.14 | 14.89 | 21.92 | 17.97 |
Source: XBRL data Amesite Inc. files with the SEC, latest filing dated Sep 23, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| AMST | $364.8K | +230.2% | -$3.10M | -848.7% | $3.4M |
| MSFT | $346.44B | +17.9% | $142.63B | 41.2% | $3.94T |
| PLTR | $7.29B | +87.1% | $3.67B | 50.3% | $386.44B |
| ORCL | $71.78B | +21.6% | $18.92B | 26.4% | $351.04B |
| SAP | €36.80B | +7.7% | €7.16B | 19.5% | $286.79B |
| CRWD | $5.40B | +24.3% | $58.46M | 1.1% | $222.09B |
| SHOP | $14.17B | +32.5% | $2.13B | 15.0% | $191.58B |
| CRM | $43.94B | +11.2% | $9.66B | 22.0% | $175.83B |
| NOW | $15.43B | +21.8% | $1.45B | 9.4% | $105.84B |